UT Southwestern Researchers Publish Link Between miRNA Dysregulation, Heart Attack

The investigators are also working with microRNA drugs startup Miragen Therapeutics to translate their findings into therapeutics for cardiac disease and other disorders.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.